Emergent BioSolutions Inc. (NYSE:EBS) will look for M&A. Chief Executive Officer Robert Kramer said, "We continue to be focused on looking opportunistically at M&A transactions that are strategically on point for the proper value. We continue to build scalable capability across our enterprise to be able to efficiently grow as we go forward. Always looking for opportunities to strengthen our R&D portfolio and of paramount importance is continuing to strengthen our overall culture in the company".